Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Vorsetuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5992-50mg

IchorBio
50 mg Login
Compare
Vorsetuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5992-5mg

IchorBio
5 mg Login
Compare
Vorsetuzumab Mafodotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5992M-0.1mg

IchorBio
0.1 mg Login
Compare
Vorsetuzumab Mafodotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5992M-1mg

IchorBio
1 mg Login
Compare
Vulinacimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5994-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Vulinacimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5994-1mg

IchorBio
1 mg Login
Compare
Vulinacimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5994-25mg

IchorBio
25 mg Login
Compare
Vulinacimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5994-50mg

IchorBio
50 mg Login
Compare
Vulinacimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5994-5mg

IchorBio
5 mg Login
Compare
Xentuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5996-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Xentuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5996-1mg

IchorBio
1 mg Login
Compare
Xentuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5996-25mg

IchorBio
25 mg Login
Compare
Xentuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5996-50mg

IchorBio
50 mg Login
Compare
Xentuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5996-5mg

IchorBio
5 mg Login
Compare
Zanidatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6002-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Zanidatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6002-1mg

IchorBio
1 mg Login
Compare
Zanidatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6002-25mg

IchorBio
25 mg Login
Compare
Zanidatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6002-50mg

IchorBio
50 mg Login
Compare
Zanidatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6002-5mg

IchorBio
5 mg Login
Compare
Zeleciment Biosimilar -­ Research Grade Hu FA CHO cells ICH6004-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Zeleciment Biosimilar -­ Research Grade Hu FA CHO cells ICH6004-1mg

IchorBio
1 mg Login
Compare
Zeleciment Biosimilar -­ Research Grade Hu FA CHO cells ICH6004-25mg

IchorBio
25 mg Login
Compare
Zeleciment Biosimilar -­ Research Grade Hu FA CHO cells ICH6004-50mg

IchorBio
50 mg Login
Compare
Zeleciment Biosimilar -­ Research Grade Hu FA CHO cells ICH6004-5mg

IchorBio
5 mg Login
Compare
Ziltivekimab Biosimilar -­ Research Grade Hu FA CHO cells ICH6008-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Name Price
Vorsetuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Vorsetuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Vorsetuzumab Mafodotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available
Vorsetuzumab Mafodotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Vulinacimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Vulinacimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Vulinacimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Vulinacimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Vulinacimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Xentuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Xentuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Xentuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Xentuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Xentuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Zanidatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Zanidatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Zanidatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Zanidatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Zanidatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Zeleciment Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Zeleciment Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Zeleciment Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Zeleciment Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Zeleciment Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Ziltivekimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available

2719 Item(s)

per page